NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

Authors :: Shailender Bhatia
Griselda Zuccarino-Catania
Suzanne McGettigan
Matthew A. Lunning
Jordan P. McPherson
Ryan M. Weight
Matthew J. Frigault
Jeffrey A. Sosman
Scott Shofer
John A. Thompson
Stephanie Andrews
Anita M. Engh
Nathan A. Pennell
Sunil Reddy
Nisha Mohindra
Alyse Johnson-Chilla
Jarushka Naidoo
Luciano J. Costa
Bryan J. Schneider
Sandip Pravin Patel
Marc S. Ernstoff
Lihua E. Budde
Philippe Armand
Marianne Davies
Yinghong Wang
Bianca Santomasso
Mabel Ryder
Benjamin H. Kaffenberger
Anthony J. Olszanski
Julie R. Brahmer
Olalekan O. Oluwole
David Dunnington
Source :: Journal of the National Comprehensive Cancer Network. 18:230-241
Publication Year :: 2020
Publisher :: Harborside Press, LLC, 2020.
Abstract: The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger further investigation, and summarize the NCCN Management of Immunotherapy-Related Toxicities Panel discussions for the 2020 update to the guidelines regarding immune checkpoint inhibitor–related diarrhea/colitis and cardiovascular irAEs.

Tools